Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
16:43:08 EDT Sun 19 May 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:RSLS
- RESHAPE LIFESCIENCES INC -
https://www.reshapelifesciences.com
16:43:08 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
RSLS
- Q
1.5
0.1715
·
0.2051
0.1
0.1762
+0.0058
3.4
6,374.0
1,060
2,674
0.19
0.2299
0.1714
2.76 0.1414
19:40:20
May 15
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Up
-- UPC Restricted:
No
Financial Status:
Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 2674
More trades...
Time ET
Ex
Price
Change
Volume
19:40:20
Q
0.178
0.0076
1,000
19:33:23
Q
0.1804
0.01
1
18:55:13
Q
0.1817
0.0113
1
18:50:55
Q
0.1731
0.0027
1,500
18:28:06
Q
0.1731
0.0027
700
18:26:21
Q
0.175
0.0046
6,000
18:20:13
Q
0.175
0.0046
1,000
18:20:05
Q
0.175
0.0046
1,000
18:00:49
Q
0.1731
0.0027
1
17:56:25
Q
0.1731
0.0027
186
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-05-15 16:05
U:RSLS
News Release
200
ReShape Lifesciences(TM) Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
2024-05-14 08:31
U:RSLS
News Release
200
ReShape Lifesciences(TM) to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
2024-04-01 16:05
U:RSLS
News Release
200
ReShape Lifesciences(TM) Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
2024-03-28 08:31
U:RSLS
News Release
200
ReShape Lifesciences(TM) Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
2024-03-04 08:31
U:RSLS
News Release
200
ReShape Lifesciences(TM) Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band(TM) 2.0 FLEX
2024-02-22 08:31
U:RSLS
News Release
200
ReShape Lifesciences ‚ ® Announces First Surgeries Utilizing Next-Generation ‚ Lap-Band ‚ ® 2.0 FLEX
2024-01-24 08:31
U:RSLS
News Release
200
ReShape Lifesciences ‚ ® Conducts Bariatric Fellows Training for its Lap-Band ‚ ® System, Highlighting the Next-Generation Lap-Band ‚ ® 2.0 FLEX
2023-12-21 07:01
U:RSLS
News Release
200
ReShape Lifesciences announces FDA PMA supplement approval for next-gen Lap-Band 2.0 Flex
2023-12-20 08:31
U:RSLS
News Release
200
ReShape Lifesciences ‚ ® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives
2023-12-12 16:05
U:RSLS
News Release
200
ReShape Lifesciences ‚ ® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band ‚ ® 2.0 FLEX
2023-11-21 08:06
U:RSLS
News Release
200
ReShape Lifesciences ‚ ® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds
2023-11-08 16:05
U:RSLS
News Release
200
ReShape Lifesciences ‚ ® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction Plan
2023-11-06 08:31
U:RSLS
News Release
200
ReShape Lifesciences ‚ ® to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate Update
2023-09-29 12:30
U:RSLS
News Release
200
ReShape Lifesciences ‚ ® Announces Pricing of $3.0 Million Public Offering
2023-09-22 08:31
U:RSLS
News Release
200
ReShape Lifesciences ‚ ® Announces Participation in the LD Micro Main Event XVI
2023-09-21 08:31
U:RSLS
News Release
200
ReShape Lifesciences ‚ ® Signs Exclusive License Agreement With Biorad Medisys for Obalon ‚ ® Gastric Balloon System
2023-09-19 08:31
U:RSLS
News Release
200
ReShape Lifesciences ‚ ® Significantly Strengthens Patent Portfolio Related to its Obalon ‚ ® Balloon System
2023-09-14 08:31
U:RSLS
News Release
200
ReShape Lifesciences ‚ ® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation ¢ „ ¢ Device
2023-08-07 16:05
U:RSLS
News Release
200
ReShape Lifesciences ‚ ® Reports Second Quarter Ended June 30, 2023 Financial Results and Provides Corporate Update
2023-08-03 16:05
U:RSLS
News Release
200
ReShape Lifesciences ‚ ® to Announce Financial Results for the Second Quarter Ended ‚ June 30, 2023 and Provide Corporate Update